Tranexamic Acid Prophylaxis During Cesarean Delivery Among Patients with and Without Hypertension
Authors:
- Mariam K. AyyashMAMariam K. Ayyash
- Adam K. LewkowitzALAdam K. Lewkowitz
- Steven J. WeinerSWSteven J. Weiner
- George R. SaadeGSGeorge R. Saade
- Samuel ParrySPSamuel Parry
- John M. ThorpJTJohn M. Thorp
- Monica LongoMLMonica Longo
- Alan T.N. TitaATAlan T.N. Tita
- Uma M. ReddyURUma M. Reddy
- Suneet P. ChauhanSCSuneet P. Chauhan
- Torri D. MetzTMTorri D. Metz
- Kara M. RoodKRKara M. Rood
- 4 November 2026
- journal article
- Published by Elsevier in American Journal of Obstetrics & Gynecology MFM
Abstract
No abstract availableFunding Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development
This publication has 4 references indexed in Scilit:
- Risk of Postpartum Hemorrhage in Hypertensive Disorders of Pregnancy: Stratified by SeverityAmerican Journal of Perinatology, 2024
- Tranexamic Acid to Prevent Obstetrical Hemorrhage after Cesarean DeliveryNew England Journal of Medicine, 2023
- Practice Bulletin No. 183: Postpartum HemorrhageObstetrics & Gynecology, 2017
- Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trialThe Lancet, 2017